Efficacy of pembrolizumab and oncolytic viral therapy in stage III esophageal cancer: a narrative review
ecancermedicalscience · 21.07.2026 · 20
DOI: 10.3332/ecancer.2026.2170 ↗Kurz gefasst
Fachartikel in der Zeitschrift ecancermedicalscience, online erschienen am 21.07.2026. Verfasst von Rajsinh Bhosale und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Pembrolizumab and oncolytic viral therapy represent promising therapeutic strategies for improving outcomes in stage III esophageal cancer. This narrative review evaluates current clinical evidence regarding their efficacy and potential role in contemporary treat-ment paradigms. A comprehensive literature search was conducted using PubMed, Google Scholar and Web of Science to identify relevant studies published between January 2010 and December 2024. Emerging evidence suggests that pembrolizumab combined with chemotherapy demonstrates encouraging pathological response rates, particularly in esophageal squamous cell carcinoma. Oncolytic viral therapy has shown potential in enhancing tumour immunogenicity and improving local tumour control; however, clinical evidence remains limited. Most available data are derived from early-phase and non-randomised studies, underscoring the need for large randomised controlled trials
Zitieren
APA
Bhosale, R., Pirzada, L., Khan, S., Zainab, A., Sivaramakrishnan, S. S., Mehmood, A. M., & Upadhya, P. S. (2026). Efficacy of pembrolizumab and oncolytic viral therapy in stage III esophageal cancer: a narrative review. ecancermedicalscience, 20. https://doi.org/10.3332/ecancer.2026.2170
Vancouver
Bhosale R, Pirzada L, Khan S, Zainab A, Sivaramakrishnan SS, Mehmood AM, et al. Efficacy of pembrolizumab and oncolytic viral therapy in stage III esophageal cancer: a narrative review. ecancermedicalscience. 2026;20. doi:10.3332/ecancer.2026.2170
BibTeX
@article{Bhosale2026,
author = {Bhosale, Rajsinh and Pirzada, Lamiya and Khan, Safiyyah and Zainab, Aqsa and Sivaramakrishnan, Shravya Subashini and Mehmood, Areeba Mariam and Upadhya, Pawan Sapkota},
title = {Efficacy of pembrolizumab and oncolytic viral therapy in stage III esophageal cancer: a narrative review},
journal = {ecancermedicalscience},
year = {2026},
volume = {20},
doi = {10.3332/ecancer.2026.2170}
}
EUVIMED